Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Nivolumab in patients with advanced hepatocellular carcin... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
0
Authors
Anthony El-Khoueiry
22 more
Anthony El-Khoueiry
•
Lixin Lang
20 more
•
Ignacio Melero
Published
April 21, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Chemistry
Cancer Oncology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1016/s0140-6736(17)31046-2
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Chemistry
Cancer Oncology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1016/s0140-6736(17)31046-2
Other Formats
PDF
